Clinical Trials on Immune Cells (Mucosal and Systemic) in France

Total 18938 results

Assistance Publique - Hôpitaux de Paris

Completed

Autonomic Nervous System and Sickle Cell Disease (DrepaSympa)

Heart Rate Variability (ANS Function)

France
University Hospital, Toulouse

Not yet recruiting

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients (HCQMa)

Mastocytosis

France
Onxeo

Completed

A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma

Austria, France, Germany, Switzerland
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies (SURPASSe)

Sezary Syndrome | Cutaneous T Lymphoma

France
Assistance Publique Hopitaux De Marseille

Terminated

LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse (LUMIER²)

Systemic Lupus Erythematosus (SLE)

France
Hospices Civils de Lyon

Completed

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia (RIPAL)

LYMPHOMA

France
Assistance Publique - Hôpitaux de Paris

Completed

Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone (DECOR)

Lupus Erythematosus, Systemic

France
University Hospital, Tours

Completed

Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus (RFPL)

Lupus Erythematosus, Systemic

France
Lymphoma Study Association
Fondation ARC

Completed

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma

Lymphoma, Large-Cell, Diffuse

France, Belgium
Centre Oscar Lambret

Recruiting

Feasibility of a New Technology for Isolating Circulating Tumour Cells (CTC-SMMiL-E)

Ovarian Cancer | Hormone-resistant Prostate Cancer | Circulating Tumor Cell | HER2-positive Metastatic Breast Cancer

France
University Hospital, Brest

Recruiting

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol (3TR-SLE1)

Systemic Lupus Erythematosus (SLE)

France
Lymphoma Study Association
Association pour le Développement de la Recherche Clinique et Informatique...

Completed

Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

B Cell Lymphoma

France
The Lymphoma Academic Research Organisation
Karyopharm Therapeutics Inc

Completed

A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP (SELINDA)

B-cell Lymphoma

Belgium, France
Assistance Publique Hopitaux De Marseille

Unknown

Psycho-social Consequences of Systemic Lupus Erythematosus

Lupus Erythematosus

France
CHU de Reims

Unknown

Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus. (R-PA14098)

Lupus Erythematosus

France
Assistance Publique - Hôpitaux de Paris

Completed

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) (REG-Allo)

Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

France
Centre Hospitalier Universitaire de Nīmes

Completed

Circulating Tumor Cells and Melanoma: Comparing the EPISPOT and CellSearch Techniques

Metastatic Melanoma

France
Centre Hospitalier Universitaire, Amiens

Unknown

Evaluation of Serum Procalcitonin Rate in Patients With Stage IV Non-small Cell Lung Cancer in First Line Chemotherapy (KBPCT)

Non Small Cells Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus (VACCILUP)

Lupus Erythematosus, Systemic

France
University Hospital, Brest

Completed

Thyroid Dysfunction and Nivolumab Reponse in NSCLC (THYRONIVO)

Non Small Cell Lung Cancer Metastatic | Prognosis | Thyroid Dysfunction | Immune Checkpoint Inhibitor | Treatment Adverse Effect

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer (PIPSeN)

Non Small Cell Lung Cancer

France
Galderma R&D

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)

Cutaneous T Cell Lymphoma

United States, France, Germany
University Hospital, Limoges
Ministry of Health, France

Completed

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

Primary Systemic Amyloidosis (AL)

France
University Hospital, Toulouse

Recruiting

Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus (LES-HYDROXY)

Lupus Erythematosus

France
Assistance Publique - Hôpitaux de Paris
Roche Diagnostics

Completed

Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus (TROPOPLUS)

Systemic Lupus Erythematosus

France
Assistance Publique - Hôpitaux de Paris

Unknown

Consequences of DNA Repair and Telomere Defects on the Function of the Immune System: Application to CVID and Immune Deficiencies With Dysmorphic Syndromes (IMMUNEREP)

Immune Deficiency and Early BMF in Childhood

France
National Cancer Institute (NCI)

Active, not recruiting

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Metastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...

United States, Canada, Ireland
Servier
Institut de Recherches Internationales Servier

Terminated

An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours. (IMMUNOPBMC)

Immune System

France
Assistance Publique - Hôpitaux de Paris

Completed

Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell Lymphoma (KIR)

Dermatitis | Sezary Syndrome | Dermatitis, Exfoliative | Mycosis Fungicides

France
CHU de Reims

Completed

Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. (THROMBLEUKEMIA)

Acute Lymphoblastic Leukemia

France
Assistance Publique - Hôpitaux de Paris
Group for Research in Adult Acute Lymphoblastic Leukemia

Completed

Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults

Leukemia, Lymphocytic

France
Assistance Publique - Hôpitaux de Paris

Completed

Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia (Campath)

Acute Lymphocytic Leukemia

France
University Hospital, Toulouse
Ministry of Health, France

Completed

Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial (GRAALL2003)

Acute Lymphoblastic Leukemia

France
University Hospital, Toulouse

Completed

Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis (EvaTryMS)

Systemic Mastocytosis

France, Martinique
Assistance Publique - Hôpitaux de Paris

Completed

Coproporphyrine Isomers and Methotrexate Elimination (COMETH)

Lymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms | Burkitt Lymphoma | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

The Montreal Cognitive Assessment.Test in Adults With Sickle Cell Disease (EvaCAD)

Sickle Cell Anemia

France
The Lymphoma Academic Research Organisation

Completed

A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas (Ro-CHOP)

Peripheral T Cell Lymphoma

France
Eli Lilly and Company

Completed

Study of LY2835219 for Mantle Cell Lymphoma

Mantle Cell Lymphoma

France, Germany
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Treatment of Mature B-cell Lymphoma/Leukaemia

B-Cell Lymphoma

France, United Kingdom, United States
Nantes University Hospital

Unknown

Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ (RIT 90YEpra)

Acute Lymphoblastic Leukemia

France
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
Advancell - Advanced In Vitro Cell Technologies...
Nexus Oncology Ltd

Completed

Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients

Leukemia, B-Cell, Chronic

Spain, France, Belgium
Vincent COTTIN
Hospices Civils de Lyon

Recruiting

National Lymphangioleiomyomatosis Registry, France (RE-LAM-CE)

Lymphangioleiomyomatosis

France
Imagine Institute

Recruiting

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions (IFN)

Autoimmune Diseases | Genetic Diseases | Neurological Disease | Immune Dysfunction

France
Hospices Civils de Lyon

Unknown

Dependence Receptors and Leukemia

Acute Lymphoblastic Leukemia | Acute Leukemia

France
French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
University Hospital, Grenoble
University Hospital, Marseille

Recruiting

Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322) (DYSALARM-322)

Lupus Erythematosus, Systemic

France
The Lymphoma Academic Research Organisation
Roche Pharma AG

Terminated

Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma

Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma

France
Institut Pasteur

Recruiting

Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. (CoSImmGEn)

Immune System and Related Disorders

France
Lymphoma Study Association

Terminated

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

CD20-Positive Large B-Cell Lymphoma

France

Clinical Trials on Immune Cells (Mucosal and Systemic) in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations